UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Looking for quick-paying work from home jobs? Explore opportunities that allow you to earn fast from home.
20,735 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
A boutique fund revealed a sizable stake in a hotel stock, signaling interest in the sector’s recovery. Here’s a prac...
Virtus InfraCap U.S. Preferred Stock ETF (PFFA) shows a 9.6% distribution yield, driven by borrowed funds. This artic...
A resurfaced clip shows Dave Ramsey endorsing a 38-foot boat purchase if net worth cushions the cost. The burn-test l...
The Trade Desk faced another slide as investors weighed AI-driven competition and fee pressure. This deep dive breaks...
A big new stake in Ryan Specialty Holdings hints at growing confidence from a niche investor. This article breaks dow...
Nexa delivered an earnings snapshot that matters for 2026. This guide breaks down the numbers, what they mean for gui...
A wave of real income is emerging in select small-cap stocks, not in the obvious dividend leaders. Analysts say real ...
Investing headlines love bold predictions, but long-term numbers rarely align with hype. This guide uses SpaceX as a ...
New data from the New York Fed show a sharp rise in household pessimism as rent and food costs rise, threatening cons...
As the space economy expands, investors face a big question: spacex rocket lab: which stock deserves a place in a gro...
Ripple's private business shows strong growth while XRP trades near a $1 price. This article builds a practical, evid...